These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7059582)

  • 1. Dopamine beta-hydroxylase: activity and inhibition in the presence of beta-substituted phenethylamines.
    Klinman JP; Krueger M
    Biochemistry; 1982 Jan; 21(1):67-75. PubMed ID: 7059582
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
    Mangold JB; Klinman JP
    J Biol Chem; 1984 Jun; 259(12):7772-9. PubMed ID: 6547439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of isotope effects to characterize intermediates in mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
    Bossard MJ; Klinman JP
    J Biol Chem; 1990 Apr; 265(10):5640-7. PubMed ID: 2318829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine beta-hydroxylase.
    Kruse LI; Kaiser C; DeWolf WE; Chambers PA; Goodhart PJ; Ezekiel M; Ohlstein EH
    J Med Chem; 1988 Apr; 31(4):704-6. PubMed ID: 3351845
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions.
    May SW; Phillips RS; Mueller PW; Herman HH
    J Biol Chem; 1981 Aug; 256(16):8470-5. PubMed ID: 7263663
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of aging on p- and m-octopamine, catecholamines, and their metabolizing enzymes in the rat.
    David JC; Coulon JF; Cavoy A; Delacour J
    J Neurochem; 1989 Jul; 53(1):149-54. PubMed ID: 2566654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.
    May SW; Mueller PW; Padgette SR; Herman HH; Phillips RS
    Biochem Biophys Res Commun; 1983 Jan; 110(1):161-8. PubMed ID: 6860408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-phenylethanolamine as a substrate for monoamine oxidase [proceedings].
    Williams CH
    Biochem Soc Trans; 1977; 5(6):1770-1. PubMed ID: 598595
    [No Abstract]   [Full Text] [Related]  

  • 9. Scope and limitation in dopamine beta-hydroxylase measurement.
    Laduron P
    Biochem Pharmacol; 1975 Mar; 24(5):557-61. PubMed ID: 1125058
    [No Abstract]   [Full Text] [Related]  

  • 10. beta-Hydroxylation as a possible detoxification mechanism: role in schizophrenia.
    Evans BD; Vogel WH
    Biol Psychiatry; 1977 Aug; 12(4):583-7. PubMed ID: 889987
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-Adrenergic blocking action of halonitrophenethanolamines.
    Letts LG; Easson PA; Temple DM; Williams LR; Pasaribu SJ; Lap BV; Lim CH
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):105-13. PubMed ID: 39529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase and dopamine beta-hydroxylase inhibiting properties of a new series of pyridazinyl hydrazones.
    Huszti Z; Szilágyi G; Kasztreiner E
    Biochem Pharmacol; 1983 Feb; 32(4):627-36. PubMed ID: 6131675
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
    Fitzpatrick PF; Harpel MR; Villafranca JJ
    Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Ross ST; Wawro J; Wise M; Flaim KE; Sawyer JL; Erickson RW
    J Med Chem; 1987 Mar; 30(3):486-94. PubMed ID: 3820219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase. Stereochemical course of the reaction.
    Taylor KB
    J Biol Chem; 1974 Jan; 249(2):454-8. PubMed ID: 4809526
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain contents of phenylethanolamine, m-octopamine and p-octopamine in the Roman strains of rats.
    David JC; Delacour J
    Brain Res; 1980 Aug; 195(1):231-5. PubMed ID: 6772269
    [No Abstract]   [Full Text] [Related]  

  • 17. Benzofurans as mechanism-based inhibitors of dopamine beta-hydroxylase.
    Farrington GK; Kumar A; Villafranca JJ
    J Med Chem; 1989 Apr; 32(4):735-7. PubMed ID: 2704022
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relations between the amine and alcohol functions of adrenaline and its hyperglycemic action. Comparative actions in the rabbit (intravenous route) of noradrenaline, ethylnoradrenaline and isoprenaline; of adrenalone, hydroxytyramine and epinine].
    Hazard R; Mouillé P
    J Physiol (Paris); 1965; 57(3):399-406. PubMed ID: 5838236
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromobacterium violaceum ω-transaminase variant Trp60Cys shows increased specificity for (S)-1-phenylethylamine and 4'-substituted acetophenones, and follows Swain-Lupton parameterisation.
    Cassimjee KE; Humble MS; Land H; Abedi V; Berglund P
    Org Biomol Chem; 2012 Jul; 10(28):5466-70. PubMed ID: 22688085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.